000 | 00967 a2200301 4500 | ||
---|---|---|---|
005 | 20250515033612.0 | ||
264 | 0 | _c20070109 | |
008 | 200701s 0 0 eng d | ||
022 | _a1001-0602 | ||
024 | 7 |
_a10.1038/sj.cr.7310082 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, Dangsheng | |
245 | 0 | 0 |
_aGSK-3beta as a driving force in ovarian cancer. _h[electronic resource] |
260 |
_bCell research _cJul 2006 |
||
300 |
_a609 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xmetabolism |
650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOvarian Neoplasms _xenzymology |
773 | 0 |
_tCell research _gvol. 16 _gno. 7 _gp. 609 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.cr.7310082 _zAvailable from publisher's website |
999 |
_c16436044 _d16436044 |